Bicycle Therapeutics PLC reports results for the quarter ended in September - Earnings Summary

Bicycle Therapeutics

03/11/2022 14:44

* Bicycle Therapeutics PLC  BCYC.OQ  reported a quarterly
adjusted
loss of 96 cents​​ per share for the quarter ended in September.
The mean expectation of fifteen analysts for the quarter was
for a loss of 89 cents per share.
    * Revenue fell 29.8% to $3.04 million from a year ago;
analysts
expected $5.47 million. 
    * Bicycle Therapeutics PLC's reported EPS for the quarter
was a
loss of 96 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Bicycle Therapeutics PLC shares had risen by 5.3% this
quarter and lost 59.8% so far this year.
    * The company reported a quarterly loss of $28.35 million.
    * Wall Street's median 12-month price target for Bicycle
Therapeutics PLC is $58.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 02:44 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.89          -0.96          Missed
 Jun. 30 2022      -0.85          -0.90          Missed
 Mar. 31 2022      -0.68          -0.93          Missed
 Dec. 31 2021      -0.61          -0.63          Missed